# Janssen Pharmaceuticals Inc. - Inspection Records

Source: https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623

> Inspection records and compliance data for Janssen Pharmaceuticals Inc. in Raritan, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Janssen Pharmaceuticals Inc.
- FEI Number: 2211100
- City: Raritan
- State: New Jersey
- Country Name: United States
- Address Line 1: 1000 U.S. Route 202 South
- Zip Code: 08869

## Related Documents

- [483 - Janssen Pharmaceuticals Inc. - Unknown Date](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/82d909e3-7138-4083-bfb4-4a18fd99a0de) — source: FDA, date: Invalid Date
- [483 - Janssen Pharmaceuticals Inc. - 2024-11-01](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/c40451a8-d847-46c1-a926-afe9ac6ef998) — source: FDA, date: November 1, 2024
- [FDA Inspection 1252007 - Janssen Pharmaceuticals Inc. - 2024-11-01](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/6cf9b413-b5b9-41ea-a1db-605ee18bf2ee) — source: FDA, date: November 1, 2024
- [483 - Janssen Pharmaceuticals Inc. - 2023-12-14](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/c421012f-38e2-4ef0-8f9f-cd8d3bea7155) — source: FDA, date: December 14, 2023
- [FDA Inspection 1225275 - Janssen Pharmaceuticals Inc. - 2023-12-14](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/f5eb5852-3f6a-4246-a387-cf35044c8d21) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2023
- [FDA Inspection 1175643 - Janssen Pharmaceuticals Inc. - 2022-06-17](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/96ba00a9-75a4-42fe-8c7e-317d1ee03074) — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2022
- [EIR - Janssen Pharmaceuticals Inc. - 2017-01-26](https://www.keypedia.com/records/eir/janssen-pharmaceuticals-inc/fed9a86c-cfbf-4828-8cff-03af0ab8f204) — source: FDA, date: January 26, 2017
- [FDA Inspection 998113 - Janssen Pharmaceuticals Inc. - 2017-01-26](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3ea6272-4a0c-4c2c-a92b-37b8191ae003) — classification: No Action Indicated (NAI), source: FDA, date: January 26, 2017
- [EIR - Janssen Pharmaceuticals Inc. - 2016-01-22](https://www.keypedia.com/records/eir/janssen-pharmaceuticals-inc/dd60c4ef-b539-4787-970f-aaf394f66a84) — source: FDA, date: January 22, 2016
- [FDA Inspection 965139 - Janssen Pharmaceuticals Inc. - 2016-01-22](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3173e7d-2caa-4560-acd5-80f483d514bf) — classification: No Action Indicated (NAI), source: FDA, date: January 22, 2016
- [FDA Inspection 833775 - Janssen Pharmaceuticals Inc. - 2013-05-21](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/7142c62c-b7f3-4997-aa1a-ced0ebfb4d44) — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2013
- [FDA Inspection 787093 - Janssen Pharmaceuticals Inc. - 2012-06-19](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/e08e9e62-12f5-45f9-a232-211fd3d1ef1e) — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012
- [FDA Inspection 740773 - Janssen Pharmaceuticals Inc. - 2011-08-22](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/5b9ce8ae-a048-4a9e-82c9-999a87ab542e) — classification: No Action Indicated (NAI), source: FDA, date: August 22, 2011
- [FDA Inspection 674432 - Janssen Pharmaceuticals Inc. - 2010-08-06](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/c8af46f0-19d5-4732-b17c-baedd973b8c5) — classification: No Action Indicated (NAI), source: FDA, date: August 6, 2010
- [FDA Inspection 556188 - Janssen Pharmaceuticals Inc. - 2009-01-15](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/782118ce-f578-4dbe-bf1e-eba48df227b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 15, 2009

## Related Companies

- [Professional Disposables International, Inc.](https://www.keypedia.com/companies/professional-disposables-international-inc/d376f414-c76e-440c-9fbf-f21b65260c53)
- [Allergan Sales LLC](https://www.keypedia.com/companies/allergan-sales-llc/cb212c1e-ac46-4323-8c3c-379a2fa7d3b2)
- [Societal CDMO Gainesville, LLC](https://www.keypedia.com/companies/societal-cdmo-gainesville-llc/6a502520-0ac5-48a2-ac38-7b93e63598cb)
- [Noble Pharma, LLC](https://www.keypedia.com/companies/noble-pharma-llc/7fd1f37f-ba04-49a3-a115-ad7110e9f8a5)
- [NEOLPHARMA, INC.](https://www.keypedia.com/companies/neolpharma-inc/4a216d1c-7206-434a-82df-ca1a8f1fe43b)
- [The Procter & Gamble Manufacturing Company](https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/bdbd5ab4-9fbf-474f-bcfb-fd22714dcbc8)
- [Regenerative Processing Plant, LLC](https://www.keypedia.com/companies/regenerative-processing-plant-llc/9460f9cb-85fa-400b-9e07-36e5b2a73133)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/4611dabc-52f7-4b4a-96bf-4196e34a7c2b)
- [V-Ensure Pharma Technologies Pvt. Limited](https://www.keypedia.com/companies/v-ensure-pharma-technologies-pvt-limited/01233430-1062-49f9-ad93-adf95ab293e8)
- [Pfizer Italia S.r.l.](https://www.keypedia.com/companies/pfizer-italia-srl/a92f2a05-0dbf-4e6f-a1e6-2c84a0f5db02)

## Related Officers

- [investigator](https://www.keypedia.com/people/michael-serrano/44c9d307-9d78-4480-b1d0-36096c056642)
- [Drug Investigator](https://www.keypedia.com/people/paul-l-bellamy/e94e1ff9-0772-4c1f-af99-a8298983e2f4)
- [Laurel A. Beer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)
- [Investigator](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)